KYVERNA THERAPEUTICS INC
KYTX·501976104·US·Common Stock·Healthcare - Biotechnology-13D/G
KYTX (KYVERNA THERAPEUTICS INC) is held by 65 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($15.4M), PRICE T ROWE ASSOCIATES INC /MD/ ($13.4M), BALYASNY ASSET MANAGEMENT L.P. ($9.7M). Net institutional sentiment: Mixed.
65
Holders
Avg rating(12 Elite)
$135.7M
Total Value
61% (68)
Fund Consensus
37 buying - 24 selling
Who's Trading
ActivistBLBain Capital Life Sciences Opportunities III, LP5.4%Feb 17, 2026
ActivistNVNorthpond Ventures III, LP4.9%Feb 17, 2026
ActivistWBWestlake BioPartners Fund I, L.P. ("Westlake Fund I")6.3%Feb 6, 2026
InsiderSCSEIDENBERG BETH CBuy $1000KDec 18, 2025
InsiderWLWestlake BioPartners Opportunity Fund I, L.P.Buy $1000KDec 18, 2025
InsiderWMWalker Karen MarieSell $293KDec 15, 2025
ActivistGGGordonMD Global Investments LP7.0%Nov 17, 2025
13F: Insider & Congress:
Showing 1-20 of 68
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer